Experimental stroke drug RNS60 passes early safety check in small trial
Disease control
Completed
This Phase 2 trial tested the safety of an experimental drug called RNS60 in 83 people having a severe stroke caused by a large blood clot. Participants received either RNS60 or a placebo as a 48-hour infusion, starting within 30 minutes of consent. The main goal was to check for…
Phase: PHASE2 • Sponsor: Revalesio Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC